Annual report pursuant to Section 13 and 15(d)

Related Party Transactions - Additional Information (Detail)

Related Party Transactions - Additional Information (Detail)						12 Months Ended
	Dec. 29, 2016 USD ($)	Sep. 30, 2016 USD ($)	Jun. 30, 2016 USD ($) Investor shares	Jun. 27, 2016 USD ($)	Dec. 01, 2015 shares	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Sep. 15, 2016	Sep. 14, 2016	Jun. 09, 2015 USD ($)
Related Party Transaction [Line Items]
Deferred payments due to former directors						$ 25,500	$ 25,500
Cash received from sale of business						1,450,000
Cash received from related parties						250,000
Accounts payable and accrued expenses						524,620	302,107
ProBiora Health, LLC [Member]
Related Party Transaction [Line Items]
Cash received from related parties						$ 26,333
ProBiora Health, LLC [Member] \| Transition Services Agreement [Member]
Related Party Transaction [Line Items]
Management fee						3.00%
Agreement term						90 days
Subletting rate per month						$ 1,623
Sublease expiration date						Feb. 28, 2017
KFLP [Member]
Related Party Transaction [Line Items]
Percentage of outstanding common stock						34.50%
Intrexon [Member]
Related Party Transaction [Line Items]
Percentage of outstanding common stock						31.50%
Accounts payable and accrued expenses						$ 524,620	302,107
Intrexon [Member] \| Lantibiotic ECC [Member]
Related Party Transaction [Line Items]
Cash paid to Intrexon Corporation						548,994	298,581
Intrexon [Member] \| Oral Mucositis ECC [Member]
Related Party Transaction [Line Items]
Cash paid to Intrexon Corporation						932,645	263,590
Deferred Payments Due to Former Directors [Member]
Related Party Transaction [Line Items]
Deferred payments due to former directors						$ 25,500	$ 25,500
Principal Owner [Member] \| Convertible Promissory Note [Member]
Related Party Transaction [Line Items]
Interest rate										3.00%
Debt instrument face amount										$ 5,000,000
Common stock issued in connection with conversion of convertible promissory note \| shares					3,381,004
Intrexon [Member] \| Principal Owner [Member]
Related Party Transaction [Line Items]
Percentage of outstanding common stock						32.00%	33.00%
Private Placement [Member]
Related Party Transaction [Line Items]
Issuance date			Jun. 30, 2016
Shares issued \| shares			9,045,679
Number of accredited investors \| Investor			3
Proceeds from issuance			$ 4,667,000
Private Placement [Member] \| KFLP [Member]
Related Party Transaction [Line Items]
Interest rate			3.00%					6.00%	3.00%
Shares issued \| shares			5,815,080
Note receivable due from sale of common stock			$ 2,000,000
Cash received from related parties	$ 1,000,000	$ 1,000,000
Extended maturity date of notes payable						Dec. 31, 2016
Private Placement [Member] \| Intrexon [Member]
Related Party Transaction [Line Items]
Shares issued \| shares			2,261,419
Dr. Frederick Telling [Member] \| Private Placement [Member]
Related Party Transaction [Line Items]
Shares issued \| shares			969,180
Discontinued Operations Disposed of by Sale [Member] \| ProBiora Health, LLC [Member]
Related Party Transaction [Line Items]
Sales price of business				$ 1,700,000
Cash received from sale of business				1,250,000
Receivable from sale of business				$ 450,000
Interest rate				1.00%
Contingent consideration payment period				10 years
Discontinued Operations Disposed of by Sale [Member] \| Maximum [Member] \| ProBiora Health, LLC [Member]
Related Party Transaction [Line Items]
Contingent consideration				$ 2,000,000